mescreen™ content strategist

Dr. Dooa Arif

PhD biomedical researcher and science writer specialising in biosensors and diagnostic technologies. Dr. Arif reviews and edits mescreen™ blog content, translating biomedical research into clear, consumer-friendly education.

Dr. Dooa Arif

Role: Content Strategist, mescreen™

Research background: Biosensors, electrochemical sensors, MOFs, nanomaterials and diagnostic technologies

Public record: ORCID 0000-0002-5356-7102 · Google Scholar h-index 7

Biography

Biomedical research, explained clearly

Dr. Dooa Arif is a biomedical researcher and science writer with a PhD in Nanoscience and Engineering and a research background in electrochemical biosensors, nanomaterials and diagnostic sensing technologies. Her work helps translate complex biomedical research into accessible, evidence-led health content.

Her doctoral work at the National University of Sciences and Technology focused on metal-organic-framework based electrochemical sensors for glucose detection. She also holds a master’s degree in Biomedical Science, where her work included antibacterial nanocomposite coatings for biomedical applications, and a bachelor’s degree in Biotechnology.

Dr. Arif’s research experience spans non-enzymatic glucose and dopamine sensing, smart hypoxia detection, functional nanocomposites, MOFs, point-of-care diagnostics, wearable and flexible bioelectronics, and laboratory methods including electrochemical analysis, microscopy, XRD and UV-Vis characterisation. That background gives her a practical understanding of how measurement technologies are developed, validated and communicated.

For mescreen™, Dr. Arif’s remit is content strategy, reviewing and editing: making sure mitochondrial-health, biomarker and diagnostics topics are explained accurately, in language that informed consumers can use.

Credentials

Research focus

Biosensors and diagnostic technologies

Dr. Arif’s publication and laboratory record is strongest in electrochemical sensing: glucose and dopamine sensors, MOF-based materials, nanocomposite interfaces and biomedical point-of-care diagnostics. Her mescreen™ role is not to present herself as a mitochondrial clinician; it is to bring PhD-level research literacy to consumer-facing biomedical education.

  • Biosensors: electrochemical sensing platforms for glucose, dopamine and hypoxia-related detection work.
  • Materials science: metal-organic frameworks including ZIF-67, MIL-68, UiO-67 and HKUST; Ag, ZnO and related nanomaterials.
  • Diagnostics: biomedical and point-of-care technologies, with interest in wearable and flexible bioelectronics.
  • Science communication: translating complex methods, evidence limits and practical implications for readers.

FAQ

Dr. Dooa Arif and mescreen™ content

What does Dr. Dooa Arif do for mescreen™?

She reviews and edits mescreen™ educational content on biomarkers, mitochondrial health, diagnostics and health-testing science, using her PhD-level background in biosensors and biomedical research.

Is Dr. Dooa Arif presented as a mitochondrial clinician?

No. Her public academic record is strongest in electrochemical biosensors, nanomaterials, MOFs and diagnostic technologies. mescreen™ presents her as a biomedical researcher and content strategist.

Is Dr. Arif’s review a medical review?

No. Her review is editorial and scientific (accuracy and clarity), not clinical. mescreen™ articles are general education and not a substitute for advice from a licensed healthcare professional.

Which public credentials support Dr. Arif’s profile?

Her public profiles show ORCID 0000-0002-5356-7102, a Google Scholar h-index of 7, five PubMed-indexed records, and a LinkedIn profile.

Recently reviewed

Recent articles reviewed by Dr. Dooa Arif

Read the mescreen™ blog

Scroll to Top